Brain-computer interface based on Rice research wins FDA approval for first clinical trial
Motif Neurotech, a company commercializing technology based on research at Rice, has received approval from the FDA to begin the first clinical trial of its therapeutic brain-computer interface for treatment of treatment-resistant depression.
An internal seed funding initiative will support 12 projects exploring brain health research.
Watch: Provost Dittmar, Project Metis leaders outline vision for brain health, brain economy
Four months after its launch, Project Metis is building momentum — with a new website and video offering a deeper look at the initiative’s vision to position the Houston-Galveston region as a global leader in brain health and the emerging brain economy.
Neuroscience meets public life at Rice’s De Lange Conference XIV: Brains in Society
Rice will host the Scientia/De Lange Conference XIV: Brains in Society from March 12 to 14.
Platform to map living brain noninvasively takes next big step
A technology designed to read gene activity in the brain from a simple blood test has now cleared a major translational hurdle.
Rice Brain Institute awards first seed grants to jump-start collaborative brain health research
The Rice Brain Institute has announced the awardees of its first funding initiative, a seed grant program that is a collaborative effort between the university and four institutional partners in the Texas Medical Center.
Rice partners on Project Metis to advance global leadership in brain health, emerging brain economy
Rice is a key partner on Project Metis, a groundbreaking initiative led by Center for Houston’s Future to position the Houston-Galveston region as the global leader in brain health and the emerging brain economy.
Materials that match the brain: Rice engineer earns Sontag Foundation distinction
Rice materials scientist and neuroengineer Christina Tringides has been named a Distinguished Scientist by the Sontag Foundation, a national recognition for early career researchers advancing transformative projects in brain cancer research.
A molecular ‘reset button’ for reading the brain through a blood test
Rice bioengineers have designed an erasable serum marker that could enable clinicians to detect problems or measure any changes in how a patient responds to treatment with greater precision, using simple, minimally-invasive testing.
Rice establishes Amyloid Research Center to tackle neurodegenerative diseases
Rice has launched the Amyloid Mechanism and Disease Center, a new campus hub dedicated to uncovering the molecular origins of Alzheimer’s, Parkinson’s and other amyloid-related diseases.
Rice and Paris Brain Institute form transatlantic partnership in brain science and innovation
The partnership follows the recent launch of the Rice Brain Institute, a universitywide effort to accelerate discoveries in brain science and health.
Nonsurgical treatment shows promise for targeted seizure control
Rice bioengineers have demonstrated a nonsurgical way to quiet a seizure-relevant brain circuit using a method that merges ultrasound, gene therapy and chemogenetics.
Rice and Houston Methodist researchers to study brain-implant interface with Dunn Foundation award
A team of researchers from Rice and the Houston Methodist Research Institute has received a John S. Dunn Foundation Collaborative Research Award through the Gulf Coast Consortia to study how the brain responds over time to neural implants.
Rice launches Brain Institute to accelerate discoveries in brain science and health
Rice has announced the creation of the Rice Brain Institute, an ambitious, interdisciplinary hub that unites faculty members across campus, including engineering, natural sciences and social sciences, to tackle one of humanity’s most complex and promising frontiers: the brain.
Algorithm maps genetic connection between Alzheimer’s and specific neurons
Rice researchers and collaborators developed a computational tool that can help identify which specific types of cells in the body are genetically linked to complex human traits and diseases, including in forms of dementia such as Alzheimer’s and Parkinson’s.
